GLP-1 Drugs: Understanding the Complexities of Coverage for Diabetes and Obesity
Posted on December 11, 2023
GLP-1 drugs have emerged as a highly effective treatment for type 2 diabetes and, more recently, weight loss. Due to their success in weight loss outcomes, these drugs have become a hot topic of discussion among pharmacy benefits experts. However, many healthcare payers are still weighing their options on the best strategy for coverage.
To help inform your 2024 benefits strategy, we have released a white paper that aims to assist plans in comprehending the subtle nuances and implications surrounding GLP-1s. Download your copy today and stay ahead of the curve!
This paper covers:
- GLP-1 Drugs: A Treatment for Both Diabetes and Obesity
- Market Demand for GLP-1 Drugs for Weight Loss
- Considerations for GLP-1 Coverage Decisions
- Strategies for GLP-1 Coverage for Weight Loss
- And more!
